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From the '.!nd Surgical Divi,ion, Kvc山 UniversityMeてlicalSchool, Kyoto 
(Director : Prof. Dr. CHUJI KIMURA) 
Clinical evaluation of a new antiinflammatoric analgesic, AP 14 (1, 3 diphenyl 5-
dimethylaminopropionyl-aminopyrazole) was undertaken. 
i) AP 1-1, 225mg a day was orally given to patients with chronic pain by means of 
the Double blind-Cross over method (As placebo lactose was adopted.). 
i) Analgesic effects on the patients were evaluated by means of the Sequential 
Analysis method, and an analgesic action of AP 1 ~ could be found. 
ii) It is accentuated that on evaluation of the analεesics, doctors in Japan are used 
to neglect the placebo actions and some of them have no consistent idea of the evalua-
tion, though a few trained doctors hav巴 foundtheir own method from the abundant ex-
periences which is the same potential as the popular methods in the clinical pharmacology. 
iv) As with the selection of the patients, it is discussed that the importance of 
differentiation with the kinds of pain has no proof, though pain from psychosomatic 
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2）投薬方法 Double blind Cn '" over methodを
用い， placeboとしては，手附iを用いた．被検才；はJm作
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analysis method (skewed de,ign, :x=O. 05, 1-~＝ O. 95, 
11=0. '!()1で解析しだ．
実験成績


























































































































出来，人道上の利点のある Sequentialanalysis method 
で判定した．
2) 慢性終痛性疾患を対象とし ζ， AP-1-lを一日
:Z25mg, Double blind-Cross over methodを用いて投与
し， placebo（乳糖〕 と比較することによって， AP-1-t
の薬効をみとめた．
3) 新北， ζとlζ鎮痛薬の臨床効果判定lζ 伴なう
．二の問題について考察した．
（本実験の実施について，武田薬品工業株式会社調
査開発都宮－； 1' ，＆夫 ・清水忠一両氏の御助力によると こ
ろが大であった。 ここに謝意を表する次第である．）
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